Showing results (91-100 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|March 21, 2022
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practiceGherardo Mazziotti, Walter Vena, Rebecca Pedersini, et al.Journal of Bone Oncology|October 29, 2021
Frequency and reason for reoperation following non-invasive expandable endoprostheses: A systematic reviewJohnathan R Lex, Amirul Adlan, Kim Tsoi, et al.Journal of Bone Oncology|March 4, 2022
Giant cell tumor of bone: A single center study of 115 casesNiklas Deventer, Tymoteusz Budny, Georg Gosheger, et al.Journal of Bone Oncology|April 1, 2022
Postoperative outcomes of subaxial cervical spine metastasis: Comparison among the anterior, posterior, and combined approachesPanya Luksanapruksa, Borriwat Santipas, Panupol Rajinda, et al.Journal of Bone Oncology|March 28, 2022
The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic propertiesLuke Tattersall, Karan M Shah, Darren L Lath, et al.Journal of Bone Oncology|August 28, 2018
Epidemiology of benign giant cell tumor of bone in the Chinese populationAlexander Liede, Rohini K Hernandez, En-Tzu Tang, et al.Journal of Bone Oncology|August 30, 2018
Extracellular vesicles-mediated signaling in the osteosarcoma microenvironment: Roles and potential therapeutic targetsMin Lan, Xiao-Ping Zhu, Zhi-Yuan Cao, et al.Journal of Bone Oncology|September 22, 2018
Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control studyHongyi Li, Xianbiao Xie, Junqiang Yin, et al.Journal of Bone Oncology|September 22, 2018
Trends in incidence of Ewing sarcoma of bone in India - Evidence from the National Cancer Registry Programme (1982-2011)Debjit Chakraborty, Sukanya Rangamani, Vaitheeswaran Kulothungan, et al.Journal of Bone Oncology|July 12, 2019
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcomaJingzhe Zhang, Ye Li, Shoujun Yang, et al.Pageof 69